Novel Method for Induction of Mucosal Immunity

Project Information
Description: 
We are attempting to secure research funds to develop a new formulation for nasal vaccines. This formulation will facilitate antigen delivery to immune cells by temporarily disrupting nasal epithelial permeability barriers. We envisage utilizing our new formulation to develop a nasal vaccine against tuberculosis. Such a vaccine would be particularly useful in countering the entrance of tubercle bacilli into the human body by inhalation and subsequent establishment of lung infections.
Project Date: 
05/01/2010 to 05/01/2011
Type of Project: 
Research
Research Area: 
Health Research
Sub-Research Area: 
Other
Funding Source: 
Other
Other Funding Source: 
We have yet to secure funding for this project.
Location: 
Canada
McGill University Project Leader Information
Role: 
Principal Investigator

    McGill Global Health Programs Logo